- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about GTHX
Recent news which mentions GTHX
Dow Gains Over 300 Points; S&P 500 Up 1%
February 13, 2023
From Benzinga
Why Frequency Therapeutics Are Trading Lower By 82%? Here Are Other Stocks Moving In Monday's Mid-Day Session
February 13, 2023
From Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
February 13, 2023
From Benzinga
Nasdaq Rises 1.5%; G1 Therapeutics Shares Plummet
February 13, 2023
From Benzinga
Stocks That Hit 52-Week Lows On Monday
February 13, 2023
From Benzinga
US Stocks Open Higher; Dow Jumps 200 Points
February 13, 2023
From Benzinga
Why Is Monday.com (MNDY) Stock Up 11% Today?
February 13, 2023
From InvestorPlace
NVAX Stock Alert: Novavax Will Provide 1.5 Million More Covid-19 Vaccine Doses to U.S.
February 13, 2023
From InvestorPlace
Why Is Sorrento Therapeutics (SRNE) Stock Down 40% Today?
February 13, 2023
From InvestorPlace
Why Is G1 Therapeutics (GTHX) Stock Down 52% Today?
February 13, 2023
From InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
February 13, 2023
From Benzinga
From InvestorPlace
G1 Therapeutics Shelves Pivotal Colorectal Trial, After Trilaciclib Triplet Therapy Favored Placebo Arm
February 13, 2023
Tickers
GTHX
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 30, 2023
January 30, 2023
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
January 05, 2023
From Benzinga
G1 Therapeutics Reveals An Early Cut Data From Bladder Cancer Trial
January 04, 2023
Tickers
GTHX
From Benzinga
Why InMed Pharmaceuticals Shares Tumbled 28%; Here Are 67 Biggest Movers From Friday
November 21, 2022
From Benzinga
Nasdaq Down 0.5%; Clearfield Shares Spike Higher
November 18, 2022
From Benzinga
Why PaxMedica Shares Are Trading Higher By Over 53%? Here Are 47 Stocks Moving In Friday's Mid-Day Session
November 18, 2022
From Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
November 18, 2022
From Benzinga
Nasdaq Turns Lower; Crude Oil Down Over 3%
November 18, 2022
From Benzinga
Delta Apparel, Farfetch, American Software And Some Other Big Stocks Moving Lower On Friday
November 18, 2022
From Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
November 18, 2022
From Benzinga
From Benzinga
From InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
November 17, 2022
From Benzinga
Why Tupperware Brands Shares Dipped Around 42%; Here Are 89 Biggest Movers From Yesterday
November 03, 2022
From Benzinga
Why Benefitfocus Shares Are Trading Higher By Around 48%? Here Are 64 Stocks Moving In Wednesday's Mid-Day Session
November 02, 2022
From Benzinga
G1 Therapeutics Says Its Lead Candidate May Cut Adverse Events Of Gilead's Breast Cancer Drug
November 02, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.